BioCryst Pharmaceuticals, Inc. (BCRX) Earnings Per Share (EPS)
BioCryst Pharmaceuticals, Inc. (BCRX) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | -$0.98 |
| 2019-12-31 | -$0.94 |
| 2020-12-31 | -$1.09 |
| 2021-12-31 | -$1.03 |
| 2022-12-31 | -$1.33 |
| 2023-12-31 | -$1.18 |
| 2024-12-31 | -$0.43 |
| 2025-12-31 | $1.26 |
How BCRX compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| ARWR | Arrowhead Pharmaceuticals Inc. | -$0.01 |
| IMUX | Immunic Inc. | -$0.62 |
| AZTA | Azenta Inc. | -$1.22 |
| IDYA | IDEAYA Biosciences Inc. | -$1.28 |
| HSDT | Helius Medical Technologies Inc. | -$1.85 |
These are five companies in the same sector as BCRX with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get BioCryst Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("BCRX")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BCRX | $9.70 | -1.22% | 2.76M |
| 3 | ||||
| 4 | ||||
| 5 |